UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 26, 2021
DERMTECH, INC.
(Exact name of registrant as specified in its charter)
| | | | |
Delaware | | 001-38118 | | 84-2870849 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
11099 N. Torrey Pines Road, Suite 100
La Jolla, CA 92037
(Address of Principal Executive Offices and Zip Code)
Registrant’s telephone number, including area code: (858) 450-4222
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock, par value $0.0001 per share | DMTK | The Nasdaq Capital Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07.Submission of Matters to a Vote of Security Holders.
DermTech, Inc., or the Company, held its 2021 Annual Meeting of Stockholders, or the Annual Meeting, on May 26, 2021. Of the Company’s 28,905,937 shares of common stock issued and outstanding and eligible to vote as of the record date of March 30, 2021, a quorum of 21,284,359 shares, or approximately 73.6% of the eligible shares, was in attendance or represented by proxy. The following actions were taken at the Annual Meeting:
Proposal 1
The stockholders elected the following nominees as Class II directors of the Company, each to serve until the Company’s 2024 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified or until their earlier death, resignation or removal. The voting results for the nominees were as follows:
| Votes For | Votes Withheld | Broker Non-Votes |
John Dobak, M.D. | 9,610,378 | 3,140,079 | 8,533,902 |
Herm Rosenman | 9,206,853 | 3,543,604 | 8,533,902 |
Gary Jacobs’ term as a director expired at the Annual Meeting and the Board of Directors did not nominate a candidate to fill the vacancy in this election cycle. Immediately following the Annual Meeting, the size of the Board of Directors was reduced to six members.
Proposal 2
The stockholders ratified the selection of KPMG LLP as the Company’s Independent Registered Public Accounting Firm for the year ending December 31, 2021. The voting results for the proposal were as follows:
Votes For | Votes Against | Abstentions | Broker Non-Votes |
21,232,365 | 38,360 | 13,634 | — |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | |
| | |
| | |
| | | | DERMTECH, INC. |
| | | |
Date: May 27, 2021 | | | | By: | | /s/ Kevin Sun |
| | | | | | Name: Kevin Sun |
| | | | | | Title: Chief Financial Officer |
